Invitrogen™ Human VLK Synthetic Peptide
VLK Synthetic Peptide, PEP-0989, from Invitrogen.
- Gene ID (Enter)
- 91461
- Species
- Human
- Purification method
- Purified
- Accession number
- Q504Y2
- Common name
- Human VLK
- Brand
- Invitrogen
VLK Synthetic Peptide, PEP-0989, from Invitrogen.
VLK Synthetic Peptide, PEP-0989, from Invitrogen.
VLK was identified as a novel protein kinase that was induced after the differentiation of cultured embryonic stem cells into mesendoderm. It has no homologs in invertebrates, but is highly conserved in vertebrate species although it does not belong to any known protein kinase groups. VLK is initially expressed in E-cadherin-positive anterior visceral endoderm and mesendoderm, but its expression is later confined to E-cadherin-negative mesenchyme. It is enriched in the Golgi apparatus and is thought to regulate the rate of protein export from the Golgi. Targeted disruption of VLK in mice leads to a defect in lung development and neonatal lethality. It has been suggested that mutations in VLK may be associated with the allergic condition atopy.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15309250 |
| Specifications | |
| Gene ID (Enter) | 91461 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q504Y2 |
| Common name | Human VLK |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | PKDCC |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-0989 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |